Skip to main content

Capula Management Ltd

Position in BSX — Boston Scientific Corp

CIK 1557017 Grand Cayman, E9

Position in BSX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$649,674
+$557,471 QoQ
Shares Held
15,222
+1474.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#779
of 1,468 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Jun 30, 2026
CallValue
$21,340
CallShares
500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Capula Management Ltd holds $28,684,593 across 4 Medical Devices names. BSX ranks #3 (2.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2
68,423 $1,702,364
3 BSX
Boston Scientific Corp
This page
15,222 $649,674

All Filings in BSX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,340 500
2026-06-30 $649,674 15,222
2025-12-31 $314,655 3,300
2025-12-31 $333,725 3,500
2025-12-31 $92,203 967
2025-09-30 $780,258 7,992
2025-09-30 $2,245,490 23,000
2025-09-30 $585,780 6,000
2025-06-30 $365,194 3,400
2025-06-30 $30,182 281
2025-06-30 $171,856 1,600
2025-03-31 $141,232 1,400
2025-03-31 $433,784 4,300
2025-03-31 $125,393 1,243
2023-03-31 $6,844,104 136,800
2023-03-31 $6,844,104 136,800
2023-03-31 $67,890 1,357
2022-12-31 $6,477,800 140,000
2022-12-31 $6,477,800 140,000
2020-12-31 $1,430,810 39,800
2020-12-31 $363,274 10,105
2020-06-30 $1,053,300 30,000
2020-06-30 $379,188 10,800